Skip to main content

Table 2 LDL-C (mg/dL) in the 19 patients who completed the study

From: LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia

  Argicolina Normolip Argicolina − Normolip
At start of treatment 153.1 ± 11.6 153.1 ± 14.4 0.0 (− 7.3  +7.3)
At end of treatment 113.1 ± 12.8 * 116.7 ± 15.4 * − 3.7 (−9.5  +2.1)
Δ Final–Initial −40.1 (−49.2  −30.9) −36.4 (−45.6  −27.1) −3.7 (−13.0  +5.6)
% Δ(Final–Initial) / Initial −25.6 (−31.1 –20.1) −23.3 (−28.7  −17.9) −2.3 (−7.4  +2.8)
  1. Data are expressed as mean ± SD, (95%CI), and analyzed by Student’s t test for paired data (end vs. start of treatment), * p < 0.0001